Chemoinformaics analysis of GAMMA-GUANIDINOPROPIONIC-ACID
| Molecular Weight | 278.436 | nRot | 13 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 4 |
| Exact Molecular Weight | 278.225 | nRing | 0 |
| Solubility: LogS | -4.975 | nHRing | 0 |
| Solubility: LogP | 6.193 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 51.6678 |
| nHD | 1 | BPOL | 30.9642 |
| QED | 0.348 |
| Synth | 2.55 |
| Natural Product Likeliness | 1.134 |
| NR-PPAR-gamma | 0.982 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -4.611 |
| MDCK | 0.00000483 |
| BBB | 0.292 |
| PPB | 0.971466 |
| VDSS | 0.6 |
| FU | 0.0233796 |
| CYP1A2-inh | 0.128 |
| CYP1A2-sub | 0.157 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.363 |
| CYP2c9-sub | 0.986 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.112 |
| CYP3a4-inh | 0.137 |
| CYP3a4-sub | 0.022 |
| CL | 5.02 |
| T12 | 0.713 |
| hERG | 0.002 |
| Ames | 0.163 |
| ROA | 0.006 |
| SkinSen | 0.968 |
| Carcinogencity | 0.094 |
| EI | 0.985 |
| Respiratory | 0.664 |
| NR-Aromatase | 0.064 |
| Antiviral | Yes |
| Prediction | 0.588874 |